Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in its Phase I/II clinical trial evaluating ...
Plexiform neurofibromas (PNF) are benign, often infiltrative tumours of the peripheral nerve sheath classically linked to ...
After a finite number of divisions, cells simply give up. As each round of replication trims their telomeres-the protective ...
Protein kinases are the molecular switches of the cell. They control growth, division, communication, and survival by ...
Smart multi-target drugs are redefining how we treat complex diseases by combining AI-driven discovery with mechanistic ...
Eli Lilly and Company (NYSE: LLY) today announced that new data from across its breast oncology portfolio and pipeline will ...
Komal Jhaveri - Breast Medical Oncologist and Early Drug Development Specialist, Memorial Sloan Kettering Cancer Center, New York, ...
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback